Increase to the high end at Day 16 of the cycle
They will look at your medical history and might do some tests
BPC-157 is a peptide sequence frequently studied in connection with cellular repair, gastrointestinal research models, soft tissue studies, and inflammatory-response pathways
While animal studies have suggested numerous potential benefits of BPC-157, there is still a lack of clarity regarding its effects, side effects, and appropriate dosing in clinical settings
A phase 2 randomised controlled trial published in the New England Journal of Medicine (2023) reported substantial weight loss and improvements in glycaemic parameters, though the trial was conducted in a closely monitored clinical setting with defined eligibility criteria
Similarly, SURMOUNT 3 showed a mean BW reduction of 18.4% with tirzepatide titrated to the maximum tolerated dose (15 mg for 86% participants) after a 72-week follow-up 35